New eye tests could speed up treatments for rare vision loss

NCT ID NCT06323772

First seen May 11, 2026 · Last updated Jun 18, 2026 · Updated 6 times

Summary

This study is for people with a specific type of retinitis pigmentosa, a genetic eye disease that causes vision loss. Researchers are testing new, detailed eye exams to see which ones best track the disease over time. The goal is to find reliable measurements that can be used in future studies of potential treatments. Participants will not receive any treatment, but will help pave the way for better clinical trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institute for Ophthalmic Research, University Tübingen

    Tübingen, Baden-Wurttemberg, 72076, Germany

Conditions

The condition(s) this trial relates to.

congenital stationary night blindness autosomal dominant 1 congenital stationary night blindness autosomal dominant 2 Eye Diseases, Hereditary eye disorder hereditary disease inherited retinal dystrophy retinal degeneration retinal disorder retinitis pigmentosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.